Your browser doesn't support javascript.
loading
SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer.
Martinez, Rafael S; Salji, Mark J; Rushworth, Linda; Ntala, Chara; Rodriguez Blanco, Giovanny; Hedley, Ann; Clark, William; Peixoto, Paul; Hervouet, Eric; Renaude, Elodie; Kung, Sonia H Y; Galbraith, Laura C A; Nixon, Colin; Lilla, Sergio; MacKay, Gillian M; Fazli, Ladan; Gaughan, Luke; Sumpton, David; Gleave, Martin E; Zanivan, Sara; Blomme, Arnaud; Leung, Hing Y.
Afiliação
  • Martinez RS; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Salji MJ; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, United Kingdom.
  • Rushworth L; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Ntala C; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, United Kingdom.
  • Rodriguez Blanco G; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Hedley A; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, United Kingdom.
  • Clark W; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Peixoto P; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, United Kingdom.
  • Hervouet E; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Renaude E; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Kung SHY; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Galbraith LCA; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Nixon C; EPIGENExp, (EPIgenetics and GENe EXPression Technical Platform), Besançon, France.
  • Lilla S; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • MacKay GM; EPIGENExp, (EPIgenetics and GENe EXPression Technical Platform), Besançon, France.
  • Fazli L; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Gaughan L; EPIGENExp, (EPIgenetics and GENe EXPression Technical Platform), Besançon, France.
  • Sumpton D; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Gleave ME; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • Zanivan S; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
  • Blomme A; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, United Kingdom.
  • Leung HY; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
Cancer Res ; 81(13): 3664-3678, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33985973
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Proteínas de Ciclo Celular / Transportador 1 de Aminoácidos Neutros Grandes / Serina-Treonina Quinases TOR / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Proteínas de Ciclo Celular / Transportador 1 de Aminoácidos Neutros Grandes / Serina-Treonina Quinases TOR / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2021 Tipo de documento: Article